Swine vesicular disease

From WikiMD's WELLNESSPEDIA

Swine vesicular disease (SVD) is a highly contagious viral disease that affects swine. It is caused by the Swine vesicular disease virus (SVDV), a member of the Picornaviridae family. The disease is characterized by the formation of vesicles, or blisters, on the feet and snout of infected pigs.

Etiology[edit]

The causative agent of Swine vesicular disease is the Swine vesicular disease virus, a single-stranded RNA virus of the genus Enterovirus within the family Picornaviridae. The virus is resistant to a wide range of pH levels and can survive in dried pork products for several months.

Clinical Signs and Diagnosis[edit]

Clinical signs of SVD include fever, lameness, and the formation of vesicles on the coronary bands, snout, and inside the mouth. The disease is often confused with Foot-and-mouth disease due to the similarity in clinical signs. Diagnosis is typically confirmed through laboratory testing, including virus isolation, serology, and polymerase chain reaction (PCR) tests.

Transmission and Epidemiology[edit]

SVD is primarily spread through direct contact with infected pigs or contaminated fomites. The virus can also be spread through the consumption of contaminated pork products. SVD has been reported in several countries in Europe and Asia, and is a notifiable disease under the World Organisation for Animal Health (OIE).

Prevention and Control[edit]

Prevention and control measures for SVD include strict biosecurity practices, movement restrictions, and the culling of infected herds. There is currently no effective vaccine for SVD.

Economic Impact[edit]

The economic impact of SVD is significant, primarily due to trade restrictions imposed on affected countries. The disease can also cause reduced growth rates and weight loss in infected pigs, leading to decreased productivity.

See Also[edit]


This animal disease related article is a stub. You can help WikiMD by expanding it.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.